Skip to content

A study comparing standard surgical repair and repair using a donated amniotic membrane patch to assess tendon healing and shoulder function in patients with shoulder tendon tears

Functional and structural outcomes of Amniotic membrane -augmented Vs Conventional arthroscopic rotator cuff repair, A randomised controlled trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/06/112330
Enrollment
56
Registered
2026-06-10
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M751- Rotator cuff tear or rupture, notspecified as traumatic

Interventions

Intervention1: Human amniotic membrane augmented rotator cuff repair: Routine technique of arthroscopic rotator cuff repair supplemented by human amniotic membrane at last step. Duration - one time su

Sponsors

RAGULAJAY B G
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Recipient Inclusion criteria (patients undergoing rotator cuff surgery) 1. Partial/full thickness rotator cuff tear 2. All traumatic tears 3. Degenerative tears with failed conservative management Donor inclusion criteria (from whom amniotic membrane will be harvested) Healthy, consenting mothers 18-35 years of age undergoing elective lower segment caesarean section (LSCS) at term (37 weeks gestation or more), with two documented negative serological screenings for HIV, HBsAg, and HCV, one during the first trimester, and one within 7 days prior to delivery

Exclusion criteria

Exclusion criteria: Recipient exclusion criteria 1. Irreparable tears 2. Associated glenohumeral arthritis/cuff tear arthropathy 3. Prior shoulder infection or surgery including revision rotator cuff surgery 4. Any pathology that may influence the assessment of outcome (Eg. neurological disorder, prior fracture or dislocation of shoulder etc.,) Donor exclusion criteria (from whom amniotic membrane will not be harvested) 1. Vaginal delivery 2. Emergency caesarean section 3. Any chronic infection or immune disorder 4. Any blood or blood product transfusion during pregnancy after the first serology test 5. Any history of high risk behaviour (intravenous drug abuse, multiple partners, sexually transmitted disease) 6. Preterm delivery (less than 37 weeks) 7. Meconium-stained liquor, intrauterine fetal demise, or premature rupture of membranes 8. Evidence or suspicion of chorioamnionitis, prolonged labor, or maternal infection 9. Suspicious gross appearance of membrane 10. Inadequate or missing serologic documentation

Design outcomes

Secondary

MeasureTime frame
Structural tendon healing between the two groups based on MRI findings using Sugaya classificationTimepoint: 9 months after surgery

Primary

MeasureTime frame
Functional outcomes between the two groups using American shoulder and elbow surgeon (ASES) score and Shoulder Pain and Disability Index (SPADI)Timepoint: Before surgery, time 0 and 9 months after surgery

Countries

India

Contacts

Public ContactRagulajay B G

All India Institute of Medical Sciences, Rishikesh

drragulajaytmc@gmail.com9486928134

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026